Myeloma Expert: Earlier Use of Bispecifics Can Improve Patient Outcomes
Drug Topics
APRIL 18, 2024
As the potential grows to use emerging bispecifics in earlier lines of myeloma therapy, so does the potential to induce better patient outcomes, said Kirollos Hanna, PharmD.
Let's personalize your content